Royal Bank Of Canada Axogen, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Axogen, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 33,320 shares of AXGN stock, worth $642,742. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,320
Previous 35,245
5.46%
Holding current value
$642,742
Previous $494,000
11.13%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$86.9 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$62.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$57 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$46.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$46.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $816M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...